Bioharvest Sciences Inc
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
▼ -87.0% over 5Y.
today you would have $148.98▼ -85.1%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $5.19 | $6.18 | $5.53 | $7.63 | |
| P/S | 5.1x | 3.4x | 4.3x | 6.0x | 18.3x |
| P/B | — | 4.6x | 80.5x | — | — |
| EPS | -$0.60 | -$0.80 | -$0.93 | -$0.70 | |
| Profit margin | -75.21% | -32.27% |
Companies of similar size in Consumer Defensive, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| YOULYoulife Group Inc. | $0.51 | 5.7x | 0.4x | — | 6.36% | $41.52M |
| GROVGrove Collaborative Holdings, Inc. | $1.00 | — | — | — | -71.89% | $42.65M |
| AACGATA Creativity Global | $0.92 | — | 0.4x | — | -6.18% | $39.76M |
| LSFLaird Superfood, Inc. | $3.92 |
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Company description provided by Yahoo Finance.
| -51.27% |
| -99.15% |
| -204.37% |
| ROE | — | -43.76% | -970.90% | — | — |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 3.9x |
| — |
| -4.14% |
| $43.88M |
| HAINHAIN Celestial Group Inc | $0.50 | — | 0.3x | — | -96.83% | $45.27M |
| STGSunlands Technology Group | $2.92 | 0.8x | 0.3x | — | 34.88% | $37.29M |